English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Gilead Sciences Inc. Healthcare Policy PAC
Bree Gonzales
| Feb 2, 2022
Molnupiravir is now the last choice for COVID-19: 'The Merck product is only 30% effective'
Trending
+
Pharmaceuticals
Patient Daily
| Jul 22, 2025
Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'
+
Pharmaceuticals
Patient Daily
| Jul 21, 2025
Executive director of COA on 340B abuse: ‘Imagine using cancer patients as a source of revenue’
Patient Daily
| Jul 24, 2025
Long School of Medicine is largest physician trainer in South Texas
Patient Daily
| Jul 25, 2025
Balloon sinuplasty marks 20 years since FDA approval
